Dose-intensified SBRT for vertebral oligometastases: results from a prospective clinical trial

Dose-intensified SBRT for vertebral oligometastases is effective and safe, even in high-risk patients with epidural or paraspinal involvement.

Authors

Institutions

Publication Details

Journal
Radiotherapy and Oncology
Published
2025-05-14
DOI
https://doi.org/10.1016/j.radonc.2025.110940
Citations
4
Primary Topic
Management of metastatic bone disease
Type
article
Field-Weighted Citation Impact
8.03

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dose-intensified SBRT for vertebral oligometastases: results from a prospective clinical trial

Jörg Zimmer, Indira Madani, Hossein Hemmatazad, Matthias Gückenberger et al.
4 citations
Radiotherapy and Oncology
Management of metastatic bone disease
8.03
article

Dose-intensified SBRT for vertebral oligometastases: results from a prospective clinical trial

Jörg Zimmer, Indira Madani, Hossein Hemmatazad, Matthias Gückenberger, Susanne Rogers, Thomas Zilli, Frank Zimmermann, Judit Boda‐Heggemann, Alessio Bruni, Daniel Schnell, Mateusz Spałek, Ciro Franzese, L. Wilke, Charlotte Billiet, Brigitta G. Baumert, Philipp Gut, Daniel M. Aebersold, Jean‐Jacques Stelmes, Franziska Nägler, Christian Weiß, Robert Förster
article en
4 citations

Abstract

Dose-intensified SBRT for vertebral oligometastases is effective and safe, even in high-risk patients with epidural or paraspinal involvement.

Radiotherapy and OncologyVol. 208
University of Bern (CH), University of Modena and Reggio Emilia (IT), Humanitas University (IT), Heidelberg University (DE), University Hospital of Bern (CH), University Medical Center Freiburg (DE), University Hospital Heidelberg (DE), University Hospital of Basel (CH), Klinik Hirslanden (CH), Klinikum Darmstadt (DE), University Hospital of Zurich (CH), Institute of Oncology Research (CH), University Hospital of Geneva (CH), Medizinisches Versorgungszentrum Prof. Mathey, Prof. Schofer (DE), University Hospital Leipzig (DE), Iridium Kankernetwerk (BE), Kantonsspital Graubünden (CH), The Maria Sklodowska-Curie National Research Institute of Oncology (PL), University Medical Centre Mannheim (DE), Kantonsspital Aarau (CH), IRCCS Humanitas Research Hospital (IT)
Varian Medical Systems, Swiss Cancer Research Foundation
Openalex Percentile: Top 3%
Management of metastatic bone disease
8.03
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.